These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 21505156)
21. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. Poon IO; Lal L; Brown EN; Braun UK J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786 [TBL] [Abstract][Full Text] [Related]
22. Epidemiology of subtherapeutic anticoagulation in the United States. Rose AJ; Ozonoff A; Grant RW; Henault LE; Hylek EM Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):591-7. PubMed ID: 20031897 [TBL] [Abstract][Full Text] [Related]
23. Quality of oral anticoagulation in patients with atrial fibrillation: a cross-sectional study in general practice. Neree C Eur J Gen Pract; 2006; 12(4):163-8. PubMed ID: 17127602 [TBL] [Abstract][Full Text] [Related]
24. Risks of oral anticoagulant therapy with increasing age. Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869 [TBL] [Abstract][Full Text] [Related]
25. The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial. Claes N; Buntinx F; Vijgen J; Arnout J; Vermylen J; Fieuws S; Van Loon H Eur Heart J; 2005 Oct; 26(20):2159-65. PubMed ID: 15917280 [TBL] [Abstract][Full Text] [Related]
28. The necessity to assess anticoagulation status in elderly injured patients. Williams TM; Sadjadi J; Harken AH; Victorino GP J Trauma; 2008 Oct; 65(4):772-6; discussion 776-7. PubMed ID: 18849789 [TBL] [Abstract][Full Text] [Related]
29. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients. Poli D; Antonucci E; Marcucci R; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D Int J Cardiol; 2009 Feb; 132(1):109-13. PubMed ID: 18180057 [TBL] [Abstract][Full Text] [Related]
30. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation. Pengo V; Cucchini U; Denas G; Davidson BL; Marzot F; Jose SP; Iliceto S Thromb Haemost; 2010 Feb; 103(2):442-9. PubMed ID: 20076843 [TBL] [Abstract][Full Text] [Related]
31. Effect of home testing of international normalized ratio on clinical events. Matchar DB; Jacobson A; Dolor R; Edson R; Uyeda L; Phibbs CS; Vertrees JE; Shih MC; Holodniy M; Lavori P; N Engl J Med; 2010 Oct; 363(17):1608-20. PubMed ID: 20961244 [TBL] [Abstract][Full Text] [Related]
32. Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation. Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR J Med Econ; 2015 May; 18(5):333-40. PubMed ID: 25549062 [TBL] [Abstract][Full Text] [Related]
33. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study. Ripley TL; Harrison D; Germany RE; Adamson PB Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987 [TBL] [Abstract][Full Text] [Related]
34. Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation. Musial J; Brzezinska-Kolarz B; Zólcinski M; Lelakowski J; Szczeklik A Clin Appl Thromb Hemost; 2010 Dec; 16(6):614-21. PubMed ID: 20460350 [TBL] [Abstract][Full Text] [Related]
35. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic. Abdelhafiz AH; Wheeldon NM Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009 [TBL] [Abstract][Full Text] [Related]
36. Quality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care. Ansell J; Caro JJ; Salas M; Dolor RJ; Corbett W; Hudnut A; Seyal S; Lordan ND; Proskorovsky I; Wygant G Am J Med Qual; 2007; 22(5):327-33. PubMed ID: 17804392 [TBL] [Abstract][Full Text] [Related]
37. Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation. Audebert HJ; Schenk B; Schenkel J; Heuschmann PU Cerebrovasc Dis; 2010; 29(5):476-83. PubMed ID: 20299787 [TBL] [Abstract][Full Text] [Related]
38. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Yasaka M; Sakata T; Naritomi H; Minematsu K Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675 [TBL] [Abstract][Full Text] [Related]
39. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population. Nochowitz B; Shapiro NL; Nutescu EA; Cavallari LH Ann Pharmacother; 2009 Jul; 43(7):1165-72. PubMed ID: 19549747 [TBL] [Abstract][Full Text] [Related]
40. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]